Browse: Departments Dates Agencies
SUBJECT CATEGORY: New Animal Drugs for Use in Animal Feeds; Lasalocid and Bacitracin Methylene Disalicylate
DOCUMENT SUMMARY: The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a new animal drug application (NADA) filed by Alpharma, Inc. The NADA provides for use of approved, singleingredient lasalocid and bacitracin methylene disalicylate Type A medicated articles to make twoway combination drug Type C medicated feeds. These combination medicated feeds are used for the prevention of coccidiosis, and for increased rate of weight gain and improved feed efficiency in growing turkeys.
SUMMARY: Lasalocid and bacitracin methylene disalicylate,
In accordance with the freedom of information provisions of 21 CFR part 20 and 514.11(e)(2)(ii), a summary of safety and effectiveness data and information submitted to support approval of this application may be seen in the Dockets Management Branch (HFA305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852, between 9 a.m. and 4 p.m., Monday through Friday.
The agency has determined under 21 CFR 25.33(a)(2) that this action is of a type that does not individually or cumulatively have a significant effect on the human environment. Therefore, neither an environmental assessment nor an environmental impact statement is required.
This rule does not meet the definition of ``rule'' in 5 U.S.C.
804(3)(A) because it is a rule of ``particular applicability.''
Therefore, it is not subject to the congressional review requirements in 5 U.S.C. 801808.
List of Subjects in 21 CFR Part 558
Animal drugs, Animal feeds.
Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine, 21 CFR part 558 is amended as follows:
1. The authority citation for 21 CFR part 558 continues to read as follows:
Authority: 21 U.S.C. 360b, 371.
2. Section 558.311 is amended in the table in paragraph (e)(1) by
alphabetically adding an item under entry (xv) following ``Bacitracin 4 to 50'' to read as follows:
Sec. 558.311 Lasalocid.
* * * * *
(e) * * *
(1) * * *
Lasalocid sodium Combination
activity in in grams per Indications Limitations Sponsor grams per ton ton for use
* * * *
* * *
(xv) 68 (0.0075
pct) to 113
(0.0125 pct)
Bacitracin 4 * * * * * * * * * to 50
Bacitracin Growing Feed 046573
methylene turkeys; for continuously disalicylate prevention as sole
4 to 50 of ration.
coccidiosis Bacitracin caused by E. methylene
meleagrimiti disalicylate
s, E. as provided gallopavonis by No.
, and E. 046573 in
adenoeides; Sec. 510.60
for 0(c) of this increased chapter.
rate of
weight gain
and improved
feed
efficiency.
* * * *
* * *
[[Page 46372]]
* * * * *
Dated: August 21, 2001.
Stephen F. Sundlof,
Director, Center for Veterinary Medicine.
[FR Doc. 0122163 Filed 9401; 8:45 am]
BILLING CODE 416001S
FOR FURTHER INFORMATION CONTACT Charles J. Andres, Center for Veterinary Medicine (HFV128), Food and Drug Administration, 7500 Standish Pl., Rockville, MD 20855, 3018271600.
14 CFR Part 39 40 CFR Part 52 14 CFR Part 71 33 CFR Part 165 50 CFR Part 679 26 CFR Part 1 40 CFR Part 180 47 CFR Part 73 50 CFR Part 17 33 CFR Part 117 44 CFR Part 67 50 CFR Part 648 14 CFR Part 97 33 CFR Part 100 40 CFR Part 63 50 CFR Part 622 26 CFR Part 301 39 CFR Part 111 40 CFR Part 300 50 CFR Part 660 44 CFR Part 65 40 CFR Parts 52 and 81 40 CFR Part 271 47 CFR Part 64 50 CFR Part 665 47 CFR Part 76 50 CFR Part 229 14 CFR Part 23 14 CFR Part 25 21 CFR Part 522